Further combining the results of ESCA and PAAD revealed that the infiltration patterns of the CD4+ T cell subsets were similar between the high- and low-CLDN18.2 expression groups across the three cancers, as were those of CD8+ T cell subsets. The gene discussed is CD4; the disease is cancer.